CVS Health Reports 6.2% Revenue Growth to $100.4 Billion in Q1 2026

CVS Health Corporation reported a significant increase in its financial performance for the first quarter of 2026, with total revenues reaching $100.4 billion, a 6.2% increase from $94.6 billion in the same period last year. The company's net income attributable to CVS Health rose to $2.943 billion, or $2.30 per diluted share, compared to $1.779 billion, or $1.41 per diluted share, in the prior year, marking a 65.4% increase in profitability. This growth was driven by revenue increases across all operating segments, particularly in the Health Services and Health Care Benefits segments.

Operating costs also increased, totaling $95.7 billion, up from $91.2 billion in the previous year, primarily due to higher costs of products sold and health care costs. The operating income for the quarter was reported at $4.68 billion, a 38.7% increase from $3.37 billion in the prior year. The effective income tax rate decreased to 24.9% from 31.9%, contributing to the overall increase in net income.

Strategically, CVS Health has continued to expand its operations, with approximately 9,000 retail locations and over 1,000 walk-in and primary care medical clinics as of March 31, 2026. The company serves around 88 million plan members through its pharmacy benefits manager and has a growing presence in specialty pharmacy solutions. The Health Care Benefits segment saw a 3.3% increase in total revenues, driven by a rise in government business, although there was a decline in the individual exchange business due to the company's exit from that market.

Operationally, CVS Health reported a decrease in medical membership to 26 million as of March 31, 2026, down from 26.6 million at the end of 2025, reflecting the exit from the individual exchange business. The Health Services segment experienced an 11% increase in revenues, attributed to pharmacy drug mix and brand inflation, despite ongoing pricing pressures. The Pharmacy & Consumer Wellness segment's revenues remained stable, with a slight increase in prescription volume, bolstered by the acquisition of Rite Aid assets.

Looking ahead, CVS Health anticipates continued challenges from market dynamics, including inflation and regulatory pressures affecting pricing and reimbursement. The company remains focused on leveraging its integrated health solutions model to enhance care delivery and improve health outcomes while managing costs effectively. The outlook for the remainder of 2026 suggests a commitment to strategic investments and operational efficiencies to sustain growth in a competitive landscape.